Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT. Cicardi M, et al. Among authors: bracho f. N Engl J Med. 2010 Aug 5;363(6):532-41. doi: 10.1056/NEJMoa0906393. N Engl J Med. 2010. PMID: 20818888 Free PMC article. Clinical Trial.
Hereditary angioedema.
Bracho FA. Bracho FA. Curr Opin Hematol. 2005 Nov;12(6):493-8. doi: 10.1097/01.moo.0000179805.57486.4e. Curr Opin Hematol. 2005. PMID: 16217168 Review.
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.
Bracho F, Krailo MD, Shen V, Bergeron S, Davenport V, Liu-Mares W, Blazar BR, Panoskaltsis-Mortari A, van de Ven C, Secola R, Ames MM, Reid JM, Reaman GH, Cairo MS. Bracho F, et al. Clin Cancer Res. 2001 Jan;7(1):58-67. Clin Cancer Res. 2001. PMID: 11205919 Clinical Trial.
Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients.
Goldman SC, Bracho F, Davenport V, Slack R, Areman E, Shen V, Lenarsky C, Weinthal J, Hughes R, Cairo MS. Goldman SC, et al. Among authors: bracho f. J Pediatr Hematol Oncol. 2001 Jun-Jul;23(5):300-5. doi: 10.1097/00043426-200106000-00013. J Pediatr Hematol Oncol. 2001. PMID: 11464987 Clinical Trial.
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
Houtenbos I, Bracho F, Davenport V, Slack R, van de Ven C, Suen Y, Killen R, Shen V, Cairo MS. Houtenbos I, et al. Among authors: bracho f. Bone Marrow Transplant. 2001 Jan;27(2):145-53. doi: 10.1038/sj.bmt.1702750. Bone Marrow Transplant. 2001. PMID: 11281383 Clinical Trial.
Rescue and rehabilitation of maned wolf (Chrysocyon brachyurus) in Paraguay: Case description.
Vetter Hiebert JR, Petters Cabrera JG, Benítez Del Puerto S, González Vatteone R, Florentín Morel M, Dacak Aguilera DA, Brítez Valinotti CE, Ramírez Diarte R, González González LM, Coronel Díaz C, Osorio P, Cardozo W, Bracho F, Soto CR, Domínguez Barreto NM, Sciabarrasi AA. Vetter Hiebert JR, et al. Among authors: bracho f. Vet Med Sci. 2024 Mar;10(2):e1395. doi: 10.1002/vms3.1395. Vet Med Sci. 2024. PMID: 38459818 Free PMC article.
17 results